News on haematological malignancies
Modular gene enhancer promotes leukaemia and regulates effectiveness of chemotherapy
Every day, billions of new blood cells are generated in the bone marrow. The gene…
Browsing: Haematology
New test predicts whether patients with blood cancer respond to therapy
A new method developed by UNSW Sydney medical researchers offers a way to predict whether…
Patients with blood cancer precursor at risk of developing cancer even after 30 years
Patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma…
In multiple myeloma, high levels of enzyme ADAR1 are associated with reduced survival
Multiple myeloma is the second most common blood cancer in the United States. Thirty to…
Missing DNA fragments hold clue to predicting childhood leukaemia relapse
Australian researchers have developed a new risk scoring system for children with leukaemia based on…
Unforeseen new drug target discovered for acute myeloid leukaemia
A study has found an unexpected new drug target for acute myeloid leukaemia (AML) that…
Therapeutic form of arsenic is a potential treatment for deadly type of brain cancer
From Sherlock Holmes to Agatha Christie, arsenic is often the poison of choice in popular…
Stealing from the body: How cancer recharges its batteries
New research uncovers how the blood cancer ‘steals’ parts of surrounding healthy bone marrow cells…
Australian Doctors Discover Woman’s “Cancer” Is Actually Tattoo Ink
Australian doctors mistook 15-year-old tattoo pigment for cancer in a case recently reported on in the Annals…
CAR T-cell therapy for leukaemia leads to remissions in clinical trial
Researchers at Fred Hutchinson Cancer Research Center showed about 70 percent of patients with the most common…